InvestSMART

BCAL Diagnostics Limited (ASX: BDX) - Announcements

Current share price for BDX : $0.081 0.004 (4.71%)+

ASX company news and announcements for BCAL Diagnostics Limited (BDX) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All BCAL Diagnostics Limited (BDX) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than BCAL Diagnostics Limited (BDX), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for BCAL Diagnostics Limited (BDX)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$30 Change of Director's Interest Notice 3 May 2023 6:52PM $0.086 $0.081 fallen by 5.81%
$30 BCAL Opens Development & Clinical Service Laboratory 3 May 2023 12:36PM $0.087 $0.081 fallen by 6.90%
$30 Quarterly Activities/Appendix 4C Cash Flow Report 24 Apr 2023 11:18AM $0.075 $0.081 risen by 8%
$30 Half Yearly Report and Accounts 23 Feb 2023 5:30PM $0.062 $0.081 risen by 30.65%
$30 Quarterly Activities/Appendix 4C Cash Flow Report 16 Jan 2023 9:07AM $0.060 $0.081 risen by 35%
$30 Results of Meeting 1 Dec 2022 7:42PM $0.059 $0.081 risen by 37.29%
$30 Results of Meeting 29 Nov 2022 5:17PM $0.059 $0.081 risen by 37.29%
$30 BCAL AGM Presentation 29 Nov 2022 2:52PM $0.059 $0.081 risen by 37.29%
$30 Shareholder Newsletter 16 Nov 2022 8:54AM $0.070 $0.081 risen by 15.71%
$30 Quarterly Activities/Appendix 4C Cash Flow Report 31 Oct 2022 8:15AM $0.066 $0.081 risen by 22.73%
$30 Letter to Shareholders on Annual General Meeting Notice 28 Oct 2022 8:02PM $0.066 $0.081 risen by 22.73%
$30 Notice of Annual General Meeting/Proxy Form 28 Oct 2022 8:00PM $0.066 $0.081 risen by 22.73%
$30 Establishment of Development & Clinical Service Laboratory 25 Oct 2022 8:54AM $0.066 $0.081 risen by 22.73%
$30 Appendix 4G and Corporate Governance Statement 29 Sep 2022 2:59PM $0.066 $0.081 risen by 22.73%
$30 Annual Report to shareholders 29 Sep 2022 11:40AM $0.066 $0.081 risen by 22.73%
$30 Preliminary Final Report 30 Aug 2022 9:52AM $0.077 $0.081 risen by 5.19%
$30 Application for quotation of securities - BDX 29 Aug 2022 7:54AM $0.080 $0.081 risen by 1.25%
$30 Proposed issue of securities - BDX 25 Aug 2022 4:24PM $0.080 $0.081 risen by 1.25%
$30 Quarterly Activities/Appendix 4C Cash Flow Report 28 Jul 2022 8:31AM $0.091 $0.081 fallen by 10.99%
$30 Change of Director's Interest Notice 4 Jul 2022 5:06PM $0.080 $0.081 risen by 1.25%
$30 BCAL Enters US Product Development Agreement with Precion 28 Jun 2022 11:14AM $0.060 $0.081 risen by 35%
$30 Change in substantial holding 27 Jun 2022 2:49PM $0.060 $0.081 risen by 35%
$30 BCAL Presentation Accepted for 2022 ASCO Annual Meeting 1 Jun 2022 8:29AM $0.096 $0.081 fallen by 15.63%
$30 Application for quotation of securities - BDX 3 May 2022 8:11AM $0.105 $0.081 fallen by 22.86%
$30 BCAL to Present at NWR Virtual Investor Conference 2 May 2022 8:22AM $0.105 $0.081 fallen by 22.86%

201 - 225 of 274 results

Page 9 of 11

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.